EUVIMEDEUVIMED entdecken
Crossref

Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression

Yujie Wang, Chenggang Hu, Ling Cao, Qi Liu, Ying Li, Tingting Zhu, Dongmei Zhang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-12 · 397 (12) · 9675-9688

DOI: 10.1007/s00210-024-03217-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 22.06.2024. Verfasst von Yujie Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephropathy, The Affiliated Hospital Of Southwest Medical University, Luzhou, 646000, Sichuan, China. wyj1026@126.com. Hauptthemen laut MEDLINE: Quercetin, Glycation End Products, Advanced, Rats, Sprague-Dawley, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: CKD-MBD Youth Research Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinGlycation End Products, AdvancedRats, Sprague-DawleyReceptor for Advanced Glycation End ProductsChronic Kidney Disease-Mineral and Bone DisorderDisease ProgressionBone DensityAnimalsMaleRatsOxidative StressKidneyMuscle, Smooth, VascularRenal Insufficiency, ChronicOsteoblastsAntioxidants

Stichwörter der Autor:innen

Advanced glycosylation end productsAngiosteosisBone metabolismChronic kidney disease–mineral and bone metabolism disorderQuercetin

Substanzen

QuercetinGlycation End Products, AdvancedReceptor for Advanced Glycation End ProductsAger protein, ratAntioxidants

Autor:innen und Institutionen

  • Department of Nephropathy, The Affiliated Hospital Of Southwest Medical University, Luzhou, 646000, Sichuan, China. wyj1026@126.com.
  • Sichuan Clinical Research Center for Nephropathy, Luzhou, 646000, Sichuan, China. wyj1026@126.com.
  • The Affiliated TCM Hospital Of Southwest Medical University, Luzhou, 646000, Sichuan, China.
  • Department of Nephropathy, The Affiliated Hospital Of Southwest Medical University, Luzhou, 646000, Sichuan, China.
  • Sichuan Clinical Research Center for Nephropathy, Luzhou, 646000, Sichuan, China.

Förderung

  • CKD-MBD Youth Research Fund Project

Zitieren

APA

Wang, Y., Hu, C., Cao, L., Liu, Q., Li, Y., Zhu, T., & Zhang, D. (2024). Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(12), 9675-9688. https://doi.org/10.1007/s00210-024-03217-1

Vancouver

Wang Y, Hu C, Cao L, Liu Q, Li Y, Zhu T, et al. Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(12):9675-9688. doi:10.1007/s00210-024-03217-1

BibTeX
@article{Wang2024,
  author = {Wang, Yujie and Hu, Chenggang and Cao, Ling and Liu, Qi and Li, Ying and Zhu, Tingting and Zhang, Dongmei},
  title = {Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  volume = {397},
  number = {12},
  pages = {9675--9688},
  doi = {10.1007/s00210-024-03217-1}
}
Kostenlos starten →